Abstract 3829: Dissecting the role of chemotherapy-induced host responses in post-therapy metastatic relapse of breast cancer

Abstract Chemotherapy-elicited host responses are regarded as a primary mechanism compromising therapeutic efficacy. Clinical evidence indicates that chemotherapy can elevate the risk of distant metastasis in certain breast cancer patients, which was also extensively observed and studied in preclinical models. In a neoadjuvant chemotherapy model, non-labeled mouse and human breast cancer cells were injected into the mouse mammary fat pad, followed by the administration of three doses of doxorubicin to mimic chemotherapy treatment. Luciferase-labeled breast cancer cells were injected into the left ventricle of the mice to establish a systemic metastasis model. In vivo bioluminescence-imaging revealed a striking increase in metastasis to the lung and liver after chemotherapy in all breast cancer mouse models, without significant metastasis to other organs. This effect was even more pronounced in NSG mice (severe immunodeficiency), suggesting that non-immune components may contribute to chemotherapy-induced metastasis. To further explore the host responses post-chemotherapy in the lung and liver, we performed single-cell RNA sequencing (scRNA-seq) to analyze non-immune cell changes following chemotherapy. This analysis identified an increased Postn (Periostin) positive mesenchymal cells subcluster in chemotherapy treated group, with upregulating collagen-processing genes, such as Col1a1 and Col3a1. Spatial transcriptomic analysis further revealed that Postn, along with collagen genes Col1a1 and Col3a1, was localized to the lung interstitial space, suggesting that extracellular matrix (ECM) remodeling in this region may facilitate metastatic colonization. We are currently investigating the role of Postn in chemotherapy-induced host responses and evaluating whether therapeutic targeting of Postn could prevent chemotherapy-induced metastasis. Citation Format: Chaojia Chen, Guangwen Ren, Zheng Gong, Jiayuan Shi. Dissecting the role of chemotherapy-induced host responses in post-therapy metastatic relapse of breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 3829.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-3829
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 3829: Dissecting the role of chemotherapy-induced host responses in post-therapy metastatic relapse of breast cancer

Guangwen Ren, Jiayuan Shi, Zheng Gong, Chaojia Chen
Cancer Research
HER2/EGFR in Cancer Research
article

Abstract 3829: Dissecting the role of chemotherapy-induced host responses in post-therapy metastatic relapse of breast cancer

Guangwen Ren, Jiayuan Shi, Zheng Gong, Chaojia Chen
article en

Abstract

Abstract Chemotherapy-elicited host responses are regarded as a primary mechanism compromising therapeutic efficacy. Clinical evidence indicates that chemotherapy can elevate the risk of distant metastasis in certain breast cancer patients, which was also extensively observed and studied in preclinical models. In a neoadjuvant chemotherapy model, non-labeled mouse and human breast cancer cells were injected into the mouse mammary fat pad, followed by the administration of three doses of doxorubicin to mimic chemotherapy treatment. Luciferase-labeled breast cancer cells were injected into the left ventricle of the mice to establish a systemic metastasis model. In vivo bioluminescence-imaging revealed a striking increase in metastasis to the lung and liver after chemotherapy in all breast cancer mouse models, without significant metastasis to other organs. This effect was even more pronounced in NSG mice (severe immunodeficiency), suggesting that non-immune components may contribute to chemotherapy-induced metastasis. To further explore the host responses post-chemotherapy in the lung and liver, we performed single-cell RNA sequencing (scRNA-seq) to analyze non-immune cell changes following chemotherapy. This analysis identified an increased Postn (Periostin) positive mesenchymal cells subcluster in chemotherapy treated group, with upregulating collagen-processing genes, such as Col1a1 and Col3a1. Spatial transcriptomic analysis further revealed that Postn, along with collagen genes Col1a1 and Col3a1, was localized to the lung interstitial space, suggesting that extracellular matrix (ECM) remodeling in this region may facilitate metastatic colonization. We are currently investigating the role of Postn in chemotherapy-induced host responses and evaluating whether therapeutic targeting of Postn could prevent chemotherapy-induced metastasis. Citation Format: Chaojia Chen, Guangwen Ren, Zheng Gong, Jiayuan Shi. Dissecting the role of chemotherapy-induced host responses in post-therapy metastatic relapse of breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 3829.

Cancer ResearchVol. 85(8_Supplement_1)
Jackson Laboratory (US)
Openalex Percentile: Top 88%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.